Join us for a webinar on CMC Considerations and Strategies for Nucleic Acid Medicines hosted by the CBA Boston Chapter!

This Saturday, Dr. Min Zhu will present "Key Considerations for a Successful CMC Strategy for mRNA Therapeutics and Comparison of FDA and CDE Requirements."

Don't miss the chance to ask questions and interact industry experts. Please scan the QR code and join us virtually via Zoom on Sept. 23rd.

• About Innoforce

Innoforce enables the innovation and global supply of plasmid DNA, RNA, and cell and gene therapeutics powered by a world-class manufacturing and development hub. With extensive expertise in process development and manufacturing of ATMPs, Innoforce can be a trusted partner for your innovative ATMP projects from R&D through commercialization.